![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 5, 2238-2244, 02, 1988
VF King, ML Garcia, D Himmel, JP Reuben, YK Lam, JX Pan, GQ Han and GJ Kaczorowski
Tetrandrine, a bis-benzylisoquinoline alkaloid derived from the Chinese
medicinal herb Stephania tetrandra, is a putative Ca2+ entry blocker whose
mechanism of action is unknown. To investigate this mechanism, the effects
of tetrandrine were characterized on binding of three chemical classes of
Ca2+ entry blockers in cardiac sarcolemmal membrane vesicles. In the range
25-37 degrees C, tetrandrine completely blocks diltiazem binding, partially
inhibits D-600 binding, and markedly stimulates nitrendipine binding, with
greatest enhancement occurring at 37 degrees C. The potency of tetrandrine
is increased 10-fold as temperature is raised from 25 to 37 degrees C.
Scatchard analyses indicate that inhibition of diltiazem binding and
stimulation of nitrendipine binding result from changes in ligand
affinities while inhibition of D-600 binding is due to both an increase in
KD and decrease in Bmax of aralkylamine receptors. Ligand dissociation
studies reveal that tetrandrine increases D-600 off-rates, decreases
nitrendipine off-rates, but has no effect on diltiazem dissociation
kinetics. In addition, tetrandrine reversibly blocks inward Ca2+ currents
through L-type Ca2+ channels in GH3 anterior pituitary cells. These results
indicate that tetrandrine interacts directly at the benzothiazepine-binding
site of the Ca2+ entry blocker receptor complex and allosterically
modulates ligand binding at other receptors in this complex. These findings
suggest that tetrandrine is a structurally unique natural product Ca2+
entry blocker and provide a rationale explanation for the therapeutic
effectiveness of this agent.
Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin
Department of Membrane Biochemistry and Biophysics, Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. B. Tikhonov and B. S. Zhorov Molecular Modeling of Benzothiazepine Binding in the L-type Calcium Channel J. Biol. Chem., June 20, 2008; 283(25): 17594 - 17604. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Safayhi, H. Haase, U. Kramer, A. Bihlmayer, M. Roenfeldt, H. P.T. Ammon, M. Froschmayr, T. N. Cassidy, I. Morano, M. K. Ahlijanian, et al. L-Type Calcium Channels in Insulin-Secreting Cells: Biochemical Characterization and Phosphorylation in RINm5F Cells Mol. Endocrinol., May 1, 1997; 11(5): 619 - 629. [Abstract] [Full Text] |
||||
![]() |
M. Hagiwara, S. Adachi-Akahane, and T. Nagao High-Affinity Binding of DTZ323, a Novel Derivative of Diltiazem, to Rabbit Skeletal Muscle L-type Ca++ Channels J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 173 - 179. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |